Position in CRBU
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$568,259
-$147,259 QoQ
Shares Held
322,875
-14.3% QoQ
Ownership
0.301%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#28
of 137 holders
Holding Since
Dec 2021
19 quarters on record
Voting authority
Sole 98%
Shared 0%
None 2%
Common Shares in CRBU Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026GOLDMAN SACHS GROUP INC holds $13,040,376,854 across 359 Biotechnology names. CRBU ranks #280 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,481,761 | $1,232,765,138 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,163,191 | $725,296,113 | |
| 3 | ROIV |
Roivant Sciences Ltd.
|
18,556,458 | $656,713,046 | |
| 4 | TECH |
BIO-TECHNE Corp
|
7,343,324 | $518,805,838 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
2,133,101 | $399,487,154 | |
| 6 | MRNA |
Moderna, Inc.
|
4,671,950 | $327,176,656 | |
| 7 | TNGX |
Tango Therapeutics, Inc.
|
9,980,620 | $311,994,180 | |
| 8 | INCY |
Incyte Corp
|
2,305,782 | $261,383,446 |
All Filings in CRBU
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $568,259 | 322,875 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $715,518 | 376,589 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $777,728 | 489,138 | Shares | Defined | 2026-03-25 | |
| 2025-09-30 | $570,439 | 244,824 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $997,435 | 791,616 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $751,252 | 822,840 | Shares | Defined | 2025-06-27 | |
| 2024-12-31 | $1,702,151 | 1,070,536 | Shares | Defined | 2025-02-11 | |
| 2024-09-30 | $1,373,748 | 700,892 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $1,949,572 | 1,188,764 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $3,098,915 | 602,902 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $3,782,028 | 660,040 | Shares | Defined | 2024-05-14 | |
| 2023-09-30 | $1,891,010 | 395,609 | Shares | Defined | 2024-05-15 | |
| 2023-06-30 | $1,150,224 | 270,641 | Shares | Defined | 2024-05-14 | |
| 2023-03-31 | $1,666,112 | 313,769 | Shares | Defined | 2024-05-14 | |
| 2022-12-31 | $2,216,192 | 352,897 | Shares | Defined | 2024-05-14 | |
| 2022-09-30 | $5,995,870 | 568,329 | Shares | Defined | 2024-05-14 | |
| 2022-06-30 | $761,925 | 140,318 | Shares | Defined | 2024-05-14 | |
| 2022-03-31 | $2,565,424 | 279,458 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $478,699 | 31,723 | Shares | Defined | 2022-02-17 | |
| No filing history on record for this holder in this stock. | ||||||